Overview / Abstract: |
Studies have shown that certain cancer therapies adversely affect the heart and lead to various types of injuries, which often result in death. This activity reviews recent advances in the management of cancer teatment-induced cardiotoxicity. STATEMENT OF NEED Several studies reveal that certain cancer therapies adversely affect the heart and lead to various types of injuries, which often result in death. Adverse cardiac effects may occur immediately after cessation of therapy or, in some cases, years after the therapy has been discontinued. Often the cardiotoxicity presents in subtle ways, and a lack of awareness results in high morbidity and mortality. It is important for oncology nurses to be aware of current advances in the management of treatment-induced cardiotoxicity as this complication limits long-term survival. TARGET AUDIENCE Oncology nurses, nurse practitioners, clinical nurse specialists, and other health care professionals involved in the treatment of patients with cancer. LEARNING OBJECTIVES Upon completion of this activity, participants should be able to: Discuss the cancer therapies associated with cardiotoxicity OCN®, CPHON®, CBCN®, AOCNP®, AOCNS®, and BMTCN® renewal candidates may apply 1 ILNA point toward: Care Continuum |
Expiration |
Dec 23, 2023 |
Discipline(s) |
Nurse Practitioner , Nursing CNE |
Format |
Webinar / Webcast / Video |
Credits / Hours |
1.0 NCPD | ILNA |
Accreditation |
ANCC |
Activity Specialities / Related Topics |
Hematology, Oncology / Cancer / Radiation Therapy |
Sponsors / Supporters / Grant Providers |
i3 Health |
Keywords / Search Terms |
i3 Health i3 Health i3 Health i3 Health i3 Health, Cardiotoxicity, oncologic emergencies, cancer treatment online CNE, free CNE, free CE CME, free CE CME, free CE CME, NCPD, free NCPD, online NCPD, online NCPD CME Free CE CME Free CE CME Free CE CME Free CE CME Free CE CME |